Patient and Caregiver Assessment Training Requirements by the FDA & EMA

This webinar is now available on demand.To view it, click the register button below and fill out the form on the registration page.

In 2016, global regulators published twelve guidances detailing rater training for clinical trials, representing a compound average growth rate (CAGR) of 42.5 in 6 years.Why the surge?Experts view inter­rater variability as a single point of failure that is avoidable if the correct precautions and training are taken.

Learn more about cognitive interviewing and effective instructional learning, find out why adding instructions to understand boundaries is counterproductive, and understand the risks of insufficient assessment training in clinical trials.

This session will familiarize you with what is expected by law, what is common practice by leading sponsors, and how you can minimize inter-rater variability among patients and caregivers.

Stay on top of current industry trends and learn why rater training is increasingly being recommended – register now!

 

Presented by:

Susan M. Dallabrida, PhD
Vice President of Clinical Science & Consulting Services
ERT

Share